White Paper
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.
February 15, 2023
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Karen Van Nuys, PhD
Research
All Research Featured Research
Journal Article
Methods to Adjust Willingness to Pay (WTP) Measures for Severity of Illness
February 14, 2023
Featured Experts: Charles E. Phelps, PhD, Darius Lakdawalla, PhD
White Paper
Price Changes Varied Widely Across California Hospital Systems from 2012 through 2018
August 18, 2022
Featured Experts: John Romley, PhD, Erin Trish, PhD, Darius Lakdawalla, PhD
Journal Article
Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials
August 10, 2022
Featured Experts: Julie Zissimopoulos, PhD, Darius Lakdawalla, PhD, Desi Peneva, MS
Journal Article
Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models
July 5, 2022
Featured Experts: Jakub Hlávka, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD
Comment Letter
Comments to the Federal Trade Commission on Pharmacy Benefit Managers
May 25, 2022
Featured Experts: Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Karen Mulligan, PhD, Neeraj Sood, PhD, Erin Trish, PhD, Karen Van Nuys, PhD
Journal Article
Impact of Non-Binding FDA Guidances On Primary Endpoint Selection in Alzheimer’s Disease Trials
March 24, 2022
Featured Experts: Jakub Hlávka, PhD, Darius Lakdawalla, PhD
Perspective
California Should Lead on Health Technology Assessment
January 27, 2022
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
How COVID Can Help Us Refocus on the How and Why of Value Assessment
October 21, 2021
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Perspective
The Hidden Cost of Covid-19: Years of Life Lost Among the Young
October 14, 2021
Featured Experts: Darius Lakdawalla, PhD
White Paper
The Social Value of Disseminating Transcatheter Aortic Valve Replacement
September 28, 2021
Featured Experts: Duncan Ermini Leaf, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD
Perspective
Federal Government Should Advise on Drug Negotiations, Not Run Them
September 23, 2021
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD
Journal Article
Measuring the COVID-19 Mortality Burden in the United States
September 21, 2021
Featured Experts: Hanke Heun-Johnson, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD
Journal Article
A Guide to Extending and Implementing Generalized Risk‑Adjusted Cost‑Effectiveness
September 8, 2021
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Journal Article
Generalized Risk-Adjusted Cost-Effectiveness (GRACE): Ensuring Patient-Centered Outcomes in Healthcare Decision Making
September 1, 2021
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Journal Article
Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis
July 30, 2021
Featured Experts: Eugene Lin, MD, MS, Khristina Ipapo Lung, MPH, Darius Lakdawalla, PhD, Jay Bhattacharya, MD, PhD
White Paper
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
July 12, 2021
Featured Experts: Alison Sexton Ward, PhD, Karen Van Nuys, PhD, Darius Lakdawalla, PhD
Perspective
FDA’s Approval of Aducanumab Paves the Way for ‘More Momentous’ Alzheimer’s Breakthroughs
June 7, 2021
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
